Articles Posted in ‘Lung cancer’

Matthew Meyerson discusses TCGA lung squamous cell cancer study

Color head shot of Matthew Meyerson, TCGA investigator, wearing glasses.

Matthew Meyerson, M.D., Ph.D., a professor of pathology from the Harvard Medical School in Cambridge, Mass., and associate professor of pathology at the Dana-Farber Cancer Institute in Boston, led the writing committee for The Cancer Genome Atlas project on lung squamous cell cancer. He recently discussed his perspective on the findings.

Overview of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

In 1993, the National Cancer Institute launched one of the largest cancer screening trials ever planned in the United States, in an effort to answer the question of screening efficacy in four cancers: prostate, lung, colorectal, and ovarian. Ten centers across the country ultimately accrued more than 150,000 men and women for this study. Nineteen years after it began, PLCO has now released the trial’s final major outcome finding, for colorectal cancer.

Changes in cancer rates when health behaviors shift [includes video]

Chart shows lung cancer incidence broken down by race

With the release of 2009 data from NCI’s SEER program on April 16, 2012, experts point to a continuing statistically significant decline in lung cancer mortality for women. This turning point was particularly important, as lung cancer is the No. 1 cancer killer for both men and women. Lung cancer cases make up nearly a quarter of all cancers deaths in the U.S. A continuation of the trends showing a drop in lung cancer mortality for both sexes would indeed be good news for the health of the nation.